CBD Gummies and Fatty Liver: What the Evidence Shows and Practical Considerations
CBD gummies fatty liver interactions are increasingly relevant due to widespread CBD use among patients with metabolic conditions. Evidence on CBD's effects on liver enzymes and drug metabolism remains limited and mixed. Understanding these interactions…
Week in Review: Clinical Breakthroughs in Metabolism, Cannabinoids, Primary Care, and AI (10/9 – 10/16/26)
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalOrganization", "@id": "https://cedclinic.com/#organization", "name": "CED Clinic",…
Week in Review: Clinical Breakthroughs in Metabolism, Cannabinoids, Primary Care, and AI (10/2 – 10/9/26)
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalOrganization", "@id": "https://cedclinic.com/#organization", "name": "CED Clinic",…
CED Cannabis Science Digest: CBD and Macrophage Inflammation, Texas Compassionate Use Access
CBD macrophage inflammation: A controlled human cell-culture study found CBD selectively reduced part of the inflammatory response in lipid-stressed macrophages, and a separate policy analysis argues Texas should add dialysis patients as a qualifying…
What the New Trial Reveals About Acute Cannabis Inflammation Response
The acute cannabis inflammation response was studied in a July 2026 trial examining high-THC exposure effects. Results showed a stronger inflammatory cytokine increase without measurable insulin sensitivity changes. This acute biomarker trial informs…
What the Latest Physiology Research Reveals About Cannabis Formulation and Diabetes Risk
A Journal of Physiology study from UC Riverside found that whole cannabis extract reversed the fat-to-pancreas signaling failure behind type 2 diabetes—while purified THC alone did not. The findings suggest the entourage effect may have direct…
Cannabis compounds may improve metabolism and reduce diabetes risk
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMetabolic HealthTHCCBDSafety Why This Matters Preclinical evidence that cannabis compounds improve insulin…
What UK Biobank Data Suggests About Cannabis, BMI, Diabetes, and Hypertension
This cannabis metabolic health study analyzed 91,002 UK Biobank participants to explore links between cannabis use, diabetes, hypertension, and obesity risk. Researchers found lower rates of several metabolic conditions among cannabis users, but BMI…
Evidence-Based Study on Cannabidiol and Glucose Tolerance
The cannabidiol glucose tolerance study examined the impact of low-dose CBD on glucose metabolism in sedentary adults with overweight or obesity. Results showed no significant improvements in glucose tolerance or gut microbiome changes. This study…
How Cannabinoid Signaling Shapes Insulin Sensitivity in Humans
Cannabinoid receptor insulin sensitivity is explored in a controlled human trial using gold-standard metabolic clamp techniques. The findings show that CB1 receptor activity can shift insulin sensitivity without altering insulin secretion. This study…
